ÂÜÀòÂÒÂ×

James Lovgren currently serves as the Chief Executive Officer and Co-Founder of Stealth Mode Biotech and holds multiple influential roles, including Screening Committee Member at the Cancer Fund and Venture Advisor at MBX Capital. Lovgren's extensive experience in the life sciences sector includes previous senior positions such as Senior Vice President of Global Marketing at MaxCyte, Inc., and Senior Director and General Manager for Cell and Gene Therapy at Thermo Fisher Scientific. With a strong educational background, including an MBA from North Carolina State University and executive programs at prestigious institutions like the University of Oxford and The Wharton School, Lovgren specializes in strategic planning, marketing, product management, and business development, demonstrating a consistent commitment to advancing innovations in healthcare and biotechnology.